These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Fundamental studies with cisplatin. Rosenberg B Cancer; 1985 May; 55(10):2303-l6. PubMed ID: 3886121 [No Abstract] [Full Text] [Related]
5. [Cis-diamminedichloroplatinum(II): a new type of cytostatic]. Sonntag RW Onkologie; 1979 Jun; 2(3):129-33. PubMed ID: 118414 [TBL] [Abstract][Full Text] [Related]
7. Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA. Pinto AL; Lippard SJ Biochim Biophys Acta; 1985; 780(3):167-80. PubMed ID: 3896310 [No Abstract] [Full Text] [Related]
8. Platinum coordination complexes in cancer chemotherapy. Rosenberg B Naturwissenschaften; 1973 Sep; 60(9):399-406. PubMed ID: 4203933 [No Abstract] [Full Text] [Related]
9. Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors. Stewart DJ; Leavens M; Maor M; Feun L; Luna M; Bonura J; Caprioli R; Loo TL; Benjamin RS Cancer Res; 1982 Jun; 42(6):2474-9. PubMed ID: 6280860 [No Abstract] [Full Text] [Related]
10. Noble metal complexes in cancer chemotherapy. Rosenberg B Adv Exp Med Biol; 1977; 91():129-50. PubMed ID: 343531 [TBL] [Abstract][Full Text] [Related]
11. Cellular uptake and toxicity study of cis-bis(6-aminoquinoline) dichloroplatinum (II). Lu MQ; Chang JC; Bergquist BL J Inorg Biochem; 1991 Jun; 42(4):231-5. PubMed ID: 1880504 [TBL] [Abstract][Full Text] [Related]
12. Modulation of antitumor alkylating agents (AA). Teicher BA; Frei E Cancer Treat Res; 1991; 57():261-95. PubMed ID: 1686721 [No Abstract] [Full Text] [Related]
13. The interaction of radiation and cis-diamminedichloroplatinum (II) in intestinal crypt cells. Luk KH; Ross GY; Phillips TL; Goldstein LS Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1417-20. PubMed ID: 575127 [No Abstract] [Full Text] [Related]
14. Cytotoxicity and influence on radiation dose response curve of cis-diamminedichloroplatinum II (cis-DDP). Murthy AK; Rossof AH; Anderson KM; Hendrickson FR Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1411-5. PubMed ID: 575126 [No Abstract] [Full Text] [Related]
15. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Ali BH; Al Moundhri MS Food Chem Toxicol; 2006 Aug; 44(8):1173-83. PubMed ID: 16530908 [TBL] [Abstract][Full Text] [Related]
16. Pressure tuning infrared spectroscopic study of cisplatin-induced structural changes in a phosphatidylserine model membrane. Taylor KD; Goel R; Shirazi FH; Molepo M; Popovic P; Stewart DJ; Wong PT Br J Cancer; 1995 Dec; 72(6):1400-5. PubMed ID: 8519651 [TBL] [Abstract][Full Text] [Related]
17. Induction and repair of DNA cross-links in chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity, and antitumor activity. Plooy AC; van Dijk M; Lohman PH Cancer Res; 1984 May; 44(5):2043-51. PubMed ID: 6538808 [TBL] [Abstract][Full Text] [Related]
18. Monitoring of effects of cis-diamminedichloroplatinum II (Platidiam). Part II. Tests for mutagenic activity in the indicator system of Salmonella typhimurium his- strains (Ames test). Vancurová M; Procházková J; Srb V Neoplasma; 1985; 32(3):307-12. PubMed ID: 3895002 [TBL] [Abstract][Full Text] [Related]
19. Cisplatin: chemistry, distribution and biotransformation. Long DF; Repta AJ Biopharm Drug Dispos; 1981; 2(1):1-16. PubMed ID: 7016212 [TBL] [Abstract][Full Text] [Related]
20. Unwinding of DNA polymerases by the antitumor drug, cis-diamminedichloroplatinum(II). Volckova E; Evanics F; Yang WW; Bose RN Chem Commun (Camb); 2003 May; (10):1128-9. PubMed ID: 12778700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]